Close
Found 0 results for your search. Showing 0 to 0.
No results could be found for your search.
x Close Search
Close

Publications

Induction of strain-transcending antibodies against Group A PfEMP1 surface antigens from virulent malaria parasites.
Ghumra, A; Semblat, J-P; Ataide, R; Kifude, C; Adams, Y; Claessens, A; Anong, DN; Bull, PC; Fennell, C; Arman, M; AMAMBUA-NGWA, A; Walther, M; CONWAY, DJ; Kassambara, L; Doumbo, OK; Raza, A; Rowe, JA;
2012
PLoS pathogens, (2012).8 4 10.1371/journal.ppat.1002665.
Potential intussusception risk versus health benefits from rotavirus vaccination in Latin America.
Desai, R; Parashar, UD; Lopman, B; De Oliveira, LH; CLARK, AD; SANDERSON, CF B; Tate, JE; Matus, CR; Andrus, JK; Patel, MM;
2012
Clinical infectious diseases, (2012).54 10 10.1093/cid/cis191.
The influence of BCG vaccine strain on mycobacteria-specific and non-specific immune responses in a prospective cohort of infants in Uganda.
Anderson, EJ; WEBB, EL; MAWA, PA; Kizza, M; Lyadda, N; Nampijja, M; ELLIOTT, AM;
2012
Vaccine, (2012).30 12 10.1016/j.vaccine.2012.01.053.
Pneumococcal polysaccharide vaccine at 12 months of age produces functional immune responses.
Licciardi, PV; Balloch, A; Russell, FM; Burton, RL; Lin, J; Nahm, MH; MULHOLLAND, EK; Tang, ML K;
2012
The Journal of allergy and clinical immunology, (2012).129 3 10.1016/j.jaci.2011.11.043.
RTS,S/AS01 Malaria Vaccine in African Children REPLY.
Hamel, MJ; Abdulla, S; GREENWOOD, B;
2012
The New England journal of medicine, (2012).366 8
Pneumococcal antibody concentrations and carriage of pneumococci more than 3 years after infant immunization with a pneumococcal conjugate vaccine.
Akinsola, AK; Ota, MO C; Enwere, GC; Okoko, BJ; ZAMAN, SM A; Saaka, M; Nsekpong, ED; ODUTOLA, AA; GREENWOOD, BM; Cutts, FT; Adegbola, RA;
2012
PloS one, (2012).7 2 10.1371/journal.pone.0031050.
BCG: myths, realities, and the need for alternative vaccine strategies.
McShane, H; Jacobs, WR; FINE, PE; Reed, SG; McMurray, DN; Behr, M; Williams, A; Orme, IM;
2012
Tuberculosis (Edinburgh, Scotland), (2012).92 3 10.1016/j.tube.2011.12.003.
Two distinct broadly neutralizing antibody specificities of different clonal lineages in a single HIV-1-infected donor: implications for vaccine design.
Bonsignori, M; Montefiori, DC; Wu, X; Chen, X; Hwang, K-K; Tsao, C-Y; Kozink, DM; Parks, RJ; Tomaras, GD; Crump, JA; KAPIGA, SH; Sam, NE; Kwong, PD; Kepler, TB; Liao, H-X; Mascola, JR; Haynes, BF;
2012
Journal of virology, (2012).86 8 10.1128/JVI.07163-11.
Variability between countries in cytokine responses to BCG vaccination: what impact might this have on protection?.
DOCKRELL, HM; SMITH, SG; Lalor, MK;
2012
Expert review of vaccines, (2012).11 2 10.1586/erv.11.186.
Monitoring the introduction of pneumococcal conjugate vaccines into West Africa: design and implementation of a population-based surveillance system.
MACKENZIE, GA; Plumb, ID; Sambou, S; Saha, D; Uchendu, U; Akinsola, B; IKUMAPAYI, UN; Baldeh, I; USUF, E; Touray, K; JASSEH, M; Howie, SR C; Wattiaux, A; Lee, E; Knoll, MD; Levine, OS; GREENWOOD, BM; Adegbola, RA; Hill, PC;
2012
PLoS medicine, (2012).9 1 10.1371/journal.pmed.1001161.